JPRN-UMIN000043775招募中未知
Impact of pharmacokinetics of Cabozantinib on clinical response and adverse event in patients with hepatocellular carcinoma - Pharmacokinetics and clinical effect of Cabozantinib
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients regarded as inappropriate subject
研究者
相似试验
招募中
2 期
The pharmacological effects of using cabozantinib with a light breakfastrenal cell carcinomakidney cancer10038364NL-OMON53521eids Universitair Medisch Centrum12
已完成
不适用
A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid TumorsNL-OMON50370Exelixis, Inc25
已完成
1 期
METBEIGE Studycolorectal cancerJPRN-jRCT2080224606ational Cancer Center Hospital East54
进行中（未招募）
1 期
Study of cabozantinib in metastatic renal carcinoma in aged fragile patientsEUCTR2019-001639-30-ESSpanish Oncology Genitourinary Group - SOGUG50
进行中（未招募）
1 期
Biomarker Phase II Study Of Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.CTIS2024-511292-15-00Grupo Espanol De Tumores Neuroendocrinos41